市場調査レポート
商品コード
1463361
疼痛管理デバイスの世界市場規模、シェア、成長分析、製品別、用途別 - 産業予測(2024~2031年)Global Pain Management Devices Market Size, Share, Growth Analysis, By Product(Electrical Stimulators, Radiofrequency Ablation (RFA)), By Application(Cancer, Neuropathic Pain) - Industry Forecast 2024-2031 |
疼痛管理デバイスの世界市場規模、シェア、成長分析、製品別、用途別 - 産業予測(2024~2031年) |
出版日: 2024年04月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
世界の疼痛管理デバイス市場規模は、2022年に約70億米ドルと評価され、2023年には76億5,000万米ドルに上昇し、予測期間中(2024-2031年)はCAGR 9.3%で2031年には155億8,000万米ドルに達すると予測されています。
慢性疾患の増加は、予測期間を通じて市場成長を促進すると予想される主な要因として際立っています。筋肉および神経刺激装置は、糖尿病や肥満などの生活習慣病が急増しているため、需要が高まっています。さらに、外傷や高血圧の有病率の上昇は、市場拡大に寄与する可能性が高いもう1つの重要な要因として特定されています。高血圧が脳動脈瘤やその他の慢性疾患のリスクを大幅に増大させることは注目に値します。COVID-19パンデミックの広範な影響は、医療機器セクターを含むほぼすべての産業に経済的影響をもたらしました。州をあげての封鎖措置は、疼痛管理のために理学療法や運動に大きく依存している患者の日常生活に支障をきたしています。また多くの選択手術や患者との面談が延期またはキャンセルされたため、在宅疼痛管理ソリューションの需要が高まると予想されています。オムロンは2020年4月、膝痛用TENS治療器「フォーカス」の新製品を発表し、薬剤を使用しない疼痛管理デバイスのラインアップを拡充することで、この需要に対応しました。加えて予測期間中に予測されるがん患者の増加が需要をさらに押し上げると予想されます。また、関節炎、変形性関節症、整形外科的変性疾患、関節リウマチなどの筋骨格系疾患の有病率は増加傾向にあります。このため、罹患者の慢性的な痛みや日常活動の制限が急増しています。例えば、CDCの推定によると、2020年にはアメリカ成人の24.5%以上が関節炎に罹患し、労働関連障害の主な原因となっています。このような慢性疼痛の有病率の増加は、結果として疼痛管理刺激装置への需要を煽っています。さらに、2020年には約3,250万人のアメリカ人が変形性関節症に罹患すると予想されています。続けて、技術の進歩が市場の成長をさらに促進し、企業のポートフォリオを大幅に拡大すると予想されています。
Global pain management devices market size was valued at around 7.0 billion in 2022 and is expected to rise from USD 7.65 billion in 2023 to reach a value of USD 15.58 billion by 2031, at a CAGR of 9.3% over the forecast period (2024-2031).
The increasing prevalence of chronic diseases stands out as a key driver expected to propel market growth throughout the forecast period. Muscle and nerve stimulators are experiencing heightened demand due to the escalating occurrence of lifestyle-related conditions such as diabetes and obesity. Additionally, the rising prevalence of trauma or hypertension is identified as another significant factor likely to contribute to market expansion. It's worth noting that hypertension significantly amplifies the risk of conditions like brain aneurysm and other chronic illnesses. The widespread impact of the COVID-19 pandemic has brought economic consequences to nearly every industry, including the medical device sector. Statewide lockdown measures have disrupted the routines of patients heavily reliant on physical therapy or exercise for pain management. Moreover, many elective surgeries and in-person patient consultations have been delayed or canceled, which is expected to drive up the demand for at-home pain management solutions. Omron responded to this demand by expanding its range of drug-free pain management devices in April 2020 with the introduction of the new Focus TENS Therapy device for knee pain. Additionally, the projected increase in cancer cases over the forecast period is anticipated to further boost demand. Furthermore, the prevalence of musculoskeletal conditions such as arthritis, osteoarthritis, orthopedic degenerative diseases, and rheumatoid arthritis is on the rise. This has led to a surge in chronic pain and limitations in daily activities among affected individuals. For instance, the CDC estimates that arthritis affected over 24.5% of American adults in 2020, making it the leading cause of work-related disability. This increased prevalence of chronic pain has consequently fueled demand for pain management stimulators. Moreover, approximately 32.5 million Americans were expected to have osteoarthritis in 2020. Furthermore, it is anticipated that technological advancements will further drive market growth, significantly expanding companies' portfolios.
Top-down and bottom-up approaches were used to estimate and validate the size of the global pain management devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pain Management Devices Market Segmental Analysis
The global pain management devices market is segmented based on product, application, and region. By product, the market is segmented into electrical stimulators, radiofrequency ablation (RFA), analgesic infusion pumps, and neurostimulation. By application, the market is segmented into cancer, neuropathic pain, facial & migraine, musculoskeletal disorder, trauma, and others. By region, the market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Drivers of the Global Pain Management Devices Market
The increasing prevalence of chronic pain conditions, including arthritis, cancer, and back pain, plays a significant role in driving the pain management device market. With a growing global population affected by various chronic pain ailments like arthritis, lower back pain, and neuropathic pain, there is a rising demand for advanced pain management solutions. These devices offer non-invasive or minimally invasive alternatives to traditional pain management methods, ultimately improving patients' comfort and quality of life. Consequently, the pain management device market is experiencing substantial growth, fueled by both healthcare professionals and patients seeking innovative and effective solutions to alleviate chronic pain while reducing their reliance on pharmaceutical treatments.
Restraints in the Global Pain Management Devices Market
The considerable expense associated with pain management devices serves as a notable impediment to market expansion. Many of these devices come with a hefty price tag, rendering them financially out of reach for certain patients and healthcare systems. This high cost presents a significant hurdle within the pain management device market, limiting access for numerous patients and healthcare facilities. As a result, their ability to acquire and utilize these advanced pain management technologies is curtailed. Consequently, the market may encounter slower adoption rates and restricted growth potential as potential customers explore more affordable options or encounter difficulties in securing the necessary funding for these devices. This scenario affects the overall dynamics of the market and poses challenges for manufacturers and providers, impacting their opportunities for growth and innovation.
Market Trends of the Global Pain Management Devices Market
There is a growing trend among patients towards seeking non-invasive pain management solutions, particularly through the use of transcutaneous electrical nerve stimulation (TENS) devices and wearable pain management devices. These options are gaining traction for their accessibility and convenience, as they offer targeted pain relief without the requirement for surgery or medication. As a result, these types of devices are becoming increasingly accessible and popular among individuals seeking effective pain management methods.